Your browser doesn't support javascript.
SARS-CoV-2 detection by extraction-free qRT-PCR for massive and rapid COVID-19 diagnosis during a pandemic in Armenia.
Avetyan, Diana; Chavushyan, Andranik; Ghazaryan, Hovsep; Melkonyan, Ani; Stepanyan, Ani; Zakharyan, Roksana; Hayrapetyan, Varduhi; Atshemyan, Sofi; Khachatryan, Gisane; Sirunyan, Tamara; Davitavyan, Suren; Martirosyan, Gevorg; Melik-Andreasyan, Gayane; Sargsyan, Shushan; Ghazazyan, Armine; Aleksanyan, Naira; Yin, Xiushan; Arakelyan, Arsen.
  • Avetyan D; Laboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia; Institute of Biomedicine and Pharmacy, Russian-Armenian University, Yerevan, 0051, Armenia. Electronic address: d_avetyan@mb.sci.am.
  • Chavushyan A; Laboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia.
  • Ghazaryan H; Laboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia.
  • Melkonyan A; Laboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia.
  • Stepanyan A; Laboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia.
  • Zakharyan R; Laboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia; Institute of Biomedicine and Pharmacy, Russian-Armenian University, Yerevan, 0051, Armenia.
  • Hayrapetyan V; Laboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia.
  • Atshemyan S; Laboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia.
  • Khachatryan G; Laboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia; Institute of Biomedicine and Pharmacy, Russian-Armenian University, Yerevan, 0051, Armenia.
  • Sirunyan T; Laboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia; Institute of Biomedicine and Pharmacy, Russian-Armenian University, Yerevan, 0051, Armenia.
  • Davitavyan S; Laboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia; Institute of Biomedicine and Pharmacy, Russian-Armenian University, Yerevan, 0051, Armenia.
  • Martirosyan G; Laboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia; Davidyants Laboratories, Yerevan, 0054, Armenia.
  • Melik-Andreasyan G; National Center of Disease Control and Prevention, Ministry of Health RA, Yerevan, 0025, Armenia.
  • Sargsyan S; National Center of Disease Control and Prevention, Ministry of Health RA, Yerevan, 0025, Armenia.
  • Ghazazyan A; National Center of Disease Control and Prevention, Ministry of Health RA, Yerevan, 0025, Armenia.
  • Aleksanyan N; National Center of Disease Control and Prevention, Ministry of Health RA, Yerevan, 0025, Armenia.
  • Yin X; Applied Biology Laboratory, Shenyang University of Chemical Technology, Shenyang, 110142, China; Biotech & Biomedicine Science (Shenyang)Co. Ltd, Shenyang, 110000, China.
  • Arakelyan A; Laboratory of Human Genomics and Immunomics, Institute of Molecular Biology, National Academy of Sciences RA, Yerevan, 0014, Armenia.
J Virol Methods ; 295: 114199, 2021 09.
Article in English | MEDLINE | ID: covidwho-1253339
ABSTRACT
COVID-19 pandemic severely impacted the healthcare and economy on a global scale. It is widely recognized that mass testing is an efficient way to contain the spread of SARS-CoV-2 infection as well as aid in the development of informed policies for disease management. However, the current COVID-19 worldwide infection rates increased the demand for rapid and reliable screening of infection. We compared the performance of qRT-PCR in direct heat-inactivated (H), heat-inactivated and pelleted (HC) samples against RNA in a group of 74 subjects (44 positive and 30 negative). Then we compared the sensitivity of HC in a larger group of 196 COVID-19 positive samples. Our study suggests that HC samples show higher accuracy for SARS-CoV-2 detection PCR assay compared to direct H (89 % vs 83 % of the detection in RNA). The sensitivity of detection using direct samples varied depending on the sample transport and storage media as well as the viral loads (as measured by qRT-PCR Ct levels). Altogether, all the data suggest that purified RNA provides more accurate results, however, direct sample testing with qRT-PCR may help to significantly increase testing capacity. Switching to the direct sample testing is justified if the number of tests is doubled at least.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mass Screening / COVID-19 Nucleic Acid Testing / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study Limits: Humans Country/Region as subject: Europa Language: English Journal: J Virol Methods Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Mass Screening / COVID-19 Nucleic Acid Testing / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study Limits: Humans Country/Region as subject: Europa Language: English Journal: J Virol Methods Year: 2021 Document Type: Article